about
Obesity and cancerModulation of human DNA topoisomerase IIalpha function by interaction with 14-3-3epsilonProteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic CancerDesigning a broad-spectrum integrative approach for cancer prevention and treatment.Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.Characterization of spontaneous and TGF-β-induced cell motility of primary human normal and neoplastic mammary cells in vitro using novel real-time technology.Resistance mechanisms of gastrointestinal cancers: why does conventional chemotherapy fail?Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-βCytotoxicity of anthracyclines: correlation with cellular uptake, intracellular distribution and DNA binding.Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impactTissue invasion and metastasis: Molecular, biological and clinical perspectives.Elevated bladder cancer risk due to colorants--a statewide case-control study in North Rhine-Westphalia, Germany.Extracellular vesicles from malignant effusions induce tumor cell migration: inhibitory effect of LMWH tinzaparin.PO-18 - Fibronectin EDA/EDB is expressed in adherent SCLC NCI-H69 cells and in pleural effusions of lung cancer patients: possible implication for drug resistance.Ionizing radiation induces a motile phenotype in human carcinoma cells in vitro through hyperactivation of the TGF-beta signaling pathway.Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.Influence of serum protein binding on the uptake and retention of idarubicin by sensitive and multidrug resistant human leukemic cells.Intermittent exposure to doxorubicin in vitro selects for multifactorial non-P-glycoprotein-associated multidrug resistance in RPMI 8226 human myeloma cells.A drug-resistant variant of topoisomerase II alpha in human HL-60 cells exhibits alterations in catalytic pH optimum, DNA binding and sub-nuclear distribution.Nuclear Topoisomerase II Activity Changes During HL-60 Leukemic Cell Differentiation: Alterations in Drug Sensitivity and pH Dependency.Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.Transforming Growth Factor-β1/Activin Receptor-like Kinase 5-Mediated Cell Migration is Dependent on the Protein Proteinase-Activated Receptor 2 but not on Proteinase-Activated Receptor 2-Stimulated Gq-Calcium Signaling."Double reflection": a practical approach to teach patient-doctor communication in oncology.Erratum to: Adult Mesenchymal Stem Cells Explored in the Dental Field.Addition of darbepoetin alfa to dose-dense chemotherapy: results from a randomized phase II trial in small-cell lung cancer patients receiving carboplatin plus etoposide.Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group.Using annexin V-coated magnetic beads to capture active tissue factor-bearing microparticles from body fluids.Adult mesenchymal stem cells explored in the dental field.Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho-Rho kinase axis and tumor microenvironment.Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling.The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility.The dilemma of gastroenterological oncology: we know a lot but we still achieve too little.Repair of idarubicin-induced DNA damage: a cause of resistance?Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal.[A 40-year-old patient with diffuse pain in the lower backbone].Correlation between the DNA-binding affinity of topoisomerase inhibiting drugs and their capacity to induce hematopoetic cell differentiation.Topoisomerase II function detected as protein-DNA complexes in two sublines of HL-60 cells.Pathophysiological considerations to thrombophilia in the treatment of multiple myeloma with thalidomide and derivates.Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer.[Obesity and cancer]
P50
Q21558465-63BFE5F1-873A-494B-86DE-AA885F50462BQ22254010-934FC0EF-7C2A-48AD-BC7A-5CEE4315FE93Q28079318-AEFC99AC-516B-4E9A-AC55-64BD79A0CBD4Q30736359-28455166-56B8-4BAD-A47A-60114EF39B53Q34570210-122B68CA-5BE6-4CE3-861A-E063E4AFFEE0Q34606919-3F2DAFF4-61E7-4545-81D7-35A42F9FDFC6Q35139963-86EC03A0-850C-4981-9334-9F709F5258CAQ35566076-E375B8C6-D53F-4B78-903B-C80C9F9ED9CAQ36737238-83BC6B59-8ED5-4998-9E0A-2E14AAFADFD6Q37348262-A6673E4C-348C-4A5D-9B1F-111429D9253EQ38417443-B355AFD5-89DA-426F-8B1F-E11F5EADF537Q38455640-112F8157-3928-43DA-AFDD-B2EC4C242C87Q38756901-5C6838F8-BCC4-40F6-BAF8-593EFB6664D3Q38772103-12873EA6-2710-4803-8194-53CC578DFE2CQ38846848-9A414B77-72C1-42D5-A154-3D0264EA8F9BQ40106388-B572641D-6029-40A9-9C95-3D1293A717C1Q40934131-8577D554-F275-4451-8A36-75CBC59D218EQ41118498-35ACED15-DEE2-44F9-89C2-0DF3A6BDA507Q41510598-EA4157EB-2407-4F5D-9319-0E3F44BF443BQ41700142-BCC5B246-DF26-4424-9D23-014929AD2F45Q42482437-C893D055-259C-45C7-9638-448F51C204CFQ42514019-3ACBC623-355F-4D1B-978A-0A141E123277Q42971343-E2A2AECB-5206-4EA1-8BD8-377B0EB506ECQ44222972-D356A2F5-EE92-4B12-AE4C-BF2653A1210DQ44803906-A401EF2C-8500-4B96-90A9-33A171107C1FQ44936612-877F7C61-6F63-44E3-AB07-77124CDF0BF5Q45126293-10C261F1-CD70-417E-B1A0-E98C03E8A1A0Q45230715-3FCCABA9-38FF-48F0-9A8B-8EA2A623FFC5Q46643195-EE6C848C-569B-4641-8E01-AF1BFCF6CC07Q47118943-86C7954A-F789-4DB1-B713-396FBC67AF45Q47277683-43C6133E-C15C-4FD2-8F35-2EA3C35BC60FQ51080112-866E5B4B-47D5-4B6E-BBA3-7F08C1AA9F1FQ52580274-11C9EEA4-7FF8-4FF6-ACFF-5698682E580FQ53475847-D0F8D45C-18EE-45EE-9F46-586E20C61824Q53898148-1D353C47-C4C3-4BBD-A08F-119683570094Q54244043-DC8AF7E2-033F-4326-AC56-567C90CA4F8EQ54244046-7B7C3B83-36DD-4CB9-91B7-E84FCBC2EAF2Q55050011-6F92EA72-8164-4441-A911-3F4F1B4880A7Q55690940-3D42D137-A3C1-434C-BB36-838A880CDE6DQ57147001-A66E7D6D-2219-47E9-8923-59318F548F8B
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Frank Gieseler
@ast
Frank Gieseler
@en
Frank Gieseler
@es
Frank Gieseler
@nl
Frank Gieseler
@sl
type
label
Frank Gieseler
@ast
Frank Gieseler
@en
Frank Gieseler
@es
Frank Gieseler
@nl
Frank Gieseler
@sl
prefLabel
Frank Gieseler
@ast
Frank Gieseler
@en
Frank Gieseler
@es
Frank Gieseler
@nl
Frank Gieseler
@sl
P214
P1053
E-8386-2012
P106
P1153
7004847440
P1960
JXS57WwAAAAJ
P21
P214
P31
P3829
P496
0000-0001-6409-3822
P734
P735
P7859
viaf-305121916